Portfolio


3SBio

IPO in 2015 (HKSE: 1530)


Aadi

IPO in 2021 (NASDAQ: AADI)


Accuragen

 


ACELYRIN

 


Adaptive Biotechnologies

IPO in 2019 (NASDAQ: ADPT)


Adela

 


AK Medical

IPO in 2017 (HKSE: 1789)


Albireo Pharma

NASDAQ: ALBO


Alpine Immune Sciences

NASDAQ: ALPN


AnHeart Therapeutics

 


Apexigen

 


Arcus Biosciences

IPO in 2018 (NASDAQ: RCUS)


Ariagen

 


Ark Biosciences

 


ARMO Biosciences

Acquired by Eli Lilly


BCFoods

 


BeyondSpring Pharmaceuticals

NASDAQ: BYSI


Bioheng

 


CardiMED

 


Cellares

 


Cellular Research

Acquired by Becton Dickinson


Centricity Vision

 


Checkmate Pharmaceuticals

IPO in 2020 (NASDAQ: CMPI)


Cirina

Acquired by GRAIL


Cue Health

IPO in 2021 (NASDAQ: HLTH)


Encodia

 


EpimAb Biotherapeutics

 


Equillium Bio

NASDAQ: EQ


Everest Medicines

IPO in 2020 (HKSE: 1952)


GenapSys

 


GeneMDx

 


GeneWEAVE

Acquired by Roche


GRAIL

Acquired by Illumina


GRIT Biotechnology

 


Guanlong Medical

 


GYT Healthcare Services

 


Hummingbird Bioscience

 


IMPACT Therapeutics

 


Insight Lifetech

 


Invitae

IPO in 2016 (NASDAQ: NVTA)


KeChow Pharma

 


Ketai Medical

 


Kind Pharmaceutical

 


LevitasBio

 


LYNK Pharmaceuticals

 


Mammoth Biosciences

 


MDCO

 


Medical Creations

 


Mindstrong Health

 


Nalu Medical

 


Omniome

Acquired by Pacific Biosciences


PackGene Biotech

 


Polares Medical

 


ReadCoor

Acquired by 10X Genomics


Scynexis

NASDAQ: SCYX


Sema4

IPO in 2021 (NASDAQ: SMFR)


SentreHEART

Acquired by Atricure


Shape Therapeutics

 


SINO Medical Sciences Technology

IPO in 2019 (SHA: 688108)


Take2

 


Take2

IPO in 2021 (NASDAQ: TERN)


VelosBio

Acquired by Merck